Adjuvant Therapy in Resected Adrenocortical Carcinoma: Current Evidence and Patient Selection

Lina Pedraza Sanchez, Guilherme Rabinowits, Elio Monsour, Prerna Dogra

Open source

DOI
10.3390/cancers18203276
Published
2026-10-11
Container
Cancers
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/cancers18203276,
  title = {Adjuvant Therapy in Resected Adrenocortical Carcinoma: Current Evidence and Patient Selection},
  author = {Lina Pedraza Sanchez and Guilherme Rabinowits and Elio Monsour and Prerna Dogra},
  year = {2026},
  journal = {Cancers},
  doi = {10.3390/cancers18203276},
  url = {https://doi.org/10.3390/cancers18203276}
}

RIS

TY  - JOUR
TI  - Adjuvant Therapy in Resected Adrenocortical Carcinoma: Current Evidence and Patient Selection
AU  - Lina Pedraza Sanchez
AU  - Guilherme Rabinowits
AU  - Elio Monsour
AU  - Prerna Dogra
PY  - 2026
JO  - Cancers
DO  - 10.3390/cancers18203276
UR  - https://doi.org/10.3390/cancers18203276
ER  - 

APA

Sanchez, L. P., Rabinowits, G., Monsour, E., & Dogra, P. (2026). Adjuvant Therapy in Resected Adrenocortical Carcinoma: Current Evidence and Patient Selection. Cancers. https://doi.org/10.3390/cancers18203276

Source records